Gassert Chad 4

What Happened
Chad Gassert, SVP – Corporate Development & Strategy at ANI Pharmaceuticals (ANIP), was granted 11,116 restricted shares on 2026-02-26 at a per-share price of $77.15 (total value ≈ $857,599). On 2026-02-28, 2,221 shares were surrendered/withheld at $73.90 per share to cover tax liabilities (proceeds value ≈ $164,132). The award is equity compensation (not an open-market purchase or sale) and the withholding is a routine tax payment.

Key Details

• Grant date: 2026-02-26; Award: 11,116 restricted shares @ $77.15 (value ≈ $857,599). (Transaction code A = Award/Grant)
• Tax withholding: 2026-02-28; 2,221 shares withheld/surrendered @ $73.90 (value ≈ $164,132). (Transaction code F = tax withholding/payment)
• Vesting: Award vests in four equal annual installments beginning 2/26/2026 (footnote F1).
• The 2,221-share withholding is in connection with tax obligations and is reported as exempt under Rule 16(b)-3 for previously reported restricted stock (footnote F2).
• Reporting note: The filer has voting/dispositive power over shares held by Chali Properties LLC (footnote F3).
• Filing: Report filed 2026-03-02 for transactions dated 2026-02-26 and 2026-02-28. (Filing appears timely based on transaction dates.)

Context
This was an equity award (restricted stock) rather than a market purchase or sale; such grants are routine compensation and do not on their own indicate insider buying or selling intent. The shares withheld were used to satisfy tax withholding obligations—a common, administrative action when restricted shares vest. The filing does not specify total shares beneficially owned by the insider after these transactions in the information you provided.